Fever, or pyrexia, is a common symptom encountered in clinical practice, often indicating an underlying inflammatory process or infection. It is a complex physiological response with a multitude of potential causes, necessitating a thorough and methodical approach to diagnosis and management.
Pyrexia is defined as a temporary increase in body temperature, often but not always due to illness. It's a protective physiological response that enhances the immune system's ability to fight off infections. The hypothalamus, acting as the body's thermostat, regulates this elevation in response to pyrogens, substances often produced during inflammation or infection.
A comprehensive history and physical examination remain the cornerstone of diagnosing the cause of fever. Laboratory investigations like complete blood count, C-reactive protein, and cultures can provide valuable information. Imaging studies may be warranted in certain cases. The clinician's challenge lies in distinguishing self-limiting conditions from serious illnesses that require immediate intervention.
Management should be directed towards the underlying cause. Symptomatic treatment with antipyretics can be considered for patient comfort, but it's important to note that fever itself is not harmful and may even be beneficial. Antipyretics should not be used to mask symptoms in serious infections. Antibiotics or antivirals may be indicated based on the etiology. Patient education about the nature and course of fever is crucial.
Pyrexia is a common clinical presentation with a wide range of potential underlying causes. A systematic approach to diagnosis, guided by clinical history and examination, is key to identifying the cause and determining the appropriate management strategy. Understanding the physiological basis of fever can help clinicians better manage this common symptom and allay patient fears.
1.
A new way to measure suicide risk?
2.
3D virtual staining technology enables non-invasive observation of cancer tissue
3.
Perioperative Nivolumab Boosts EFS Versus Neoadjuvant-Only Nivolumab in NSCLC
4.
I Understand Why Defense Secretary Austin Kept His Prostate Cancer Quiet.
5.
ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations
1.
Hemophilia B and Gene Therapy: A New Chapter with Etranacogene Dezaparvovec
2.
Driving Impact: Oncology Pharmaceutical Marketing Strategies in the USA
3.
7 Subtle Signs of Leukemia: How to Spot the Symptoms Early
4.
Predicting Incidental Prostate Cancer in BPH Surgery Patients
5.
How Should We Approach Solid Pseudopapillary Neoplasm of the Pancreas with Hepatic Metastases?
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
2.
The Comprehensive Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2.
3.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
4.
Unmet Needs in ALK Positive NSCLC- The Challenges in the Current Care
5.
Navigating the Complexities of Ph Negative ALL - Part IX
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation